| 000 | 01881 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513210944.0 | ||
| 264 | 0 | _c20000608 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0363-6119 | ||
| 024 | 7 |
_a10.1152/ajpregu.2000.278.5.R1232 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPulido, E J | |
| 245 | 0 | 0 |
_aDifferential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Regulatory, integrative and comparative physiology _cMay 2000 |
||
| 300 |
_aR1232-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 | _aEnzyme Inhibitors |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xanalysis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
| 650 | 0 | 4 | _aSalmonella typhimurium |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
| 700 | 1 | _aShames, B D | |
| 700 | 1 | _aFullerton, D A | |
| 700 | 1 | _aSheridan, B C | |
| 700 | 1 | _aSelzman, C H | |
| 700 | 1 | _aGamboni-Robertson, F | |
| 700 | 1 | _aBensard, D D | |
| 700 | 1 | _aMcIntyre, R C | |
| 773 | 0 |
_tAmerican journal of physiology. Regulatory, integrative and comparative physiology _gvol. 278 _gno. 5 _gp. R1232-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpregu.2000.278.5.R1232 _zAvailable from publisher's website |
| 999 |
_c10753460 _d10753460 |
||